Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders.

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Abstract Text:

    j mcdermidJ McDermid,m chenM Chen,y liY Li,s wasilenkoS Wasilenko,j bintnerJ Bintner,c mcdougallC McDougall,x pangX Pang,v g bainV G Bain,a l masonA L Mason,

    BACKGROUND: Patients with biliary disease make retroviral antibodies and the Human Betaretrovirus has been characterized in patients with primary biliary cirrhosis. AIM: To screen patients with autoimmune liver disease for evidence of retroviral infection. METHODS: Real-time reverse transcriptase polymerase chain reaction was used to detect Human Betaretrovirus, and a reverse transcriptase assay to measure reverse transcriptase activity in plasma. RESULTS: Using reverse transcriptase polymerase chain reaction, 24% of primary biliary cirrhosis samples were positive for Human Betaretrovirus when compared to 13% with autoimmune hepatitis, 5% of other liver diseases and 3% of the non-liver disease control subjects. Reverse transcriptase activity was found in 73% of patients with autoimmune hepatitis, 42% with primary biliary cirrhosis, 22% of liver patients without viral or autoimmune disease and 7% of subjects without liver disease. In patients with autoimmune liver disease, detection of reverse transcriptase activity was related to higher ALT levels, whereas others stabilized on immunosuppressive therapy either preliver or postliver transplantation were less likely to be reverse transcriptase-positive. CONCLUSIONS: Most patients with autoimmune hepatitis have detectable reverse transcriptase activity. Investigations will be required to assess whether this represents the expression of endogenous retroviruses and retrotransposable elements in inflamed tissue, or signifies the presence of exogenous retroviral infection.

    Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Publishing Authors By Initials

    j mcdermidJ McDermid,m chenM Chen,y liY Li,s wasilenkoS Wasilenko,j bintnerJ Bintner,c mcdougallC McDougall,x pangX Pang,vg bainVG Bain,al masonAL Mason,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Alimentary pharmacology & therapeutics

    VOLUME: 26

    Page Numbers: 587-95

    Journal Abbreviation: Aliment. Pharmacol. Ther.

    ISSN: 0269-2813

    DAY: 15

    MONTH: Aug

    YEAR: 2007

    Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8707234

    Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Keywords Mesh Terms:

    KEYWORDS: Reverse Transcriptase Polymerase Chain R

    MESH TERMS: prevention & control

    Chemical & Substance for Abstract: Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Information

    Substance Name: Autoantigens

    Registry Number: 0

    Grant and Affiliation Information for Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders.

    AFFILIATION: Department of Medicine, University of Alberta, Alberta, Canada.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Aliment Pharmacol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News